|
Volumn 21, Issue 5, 2010, Pages 852-858
|
Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCYSTEINE;
ANTIANEMIC AGENT;
ANTIOXIDANT;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
FERRIC ION;
FERRIC OXIDE, SACCHARATED;
MALONALDEHYDE;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HUMAN;
INDIA;
INTRAVENOUS DRUG ADMINISTRATION;
IRON DEFICIENCY ANEMIA;
LIPID PEROXIDATION;
MALE;
METABOLISM;
MIDDLE AGED;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PLACEBO EFFECT;
PLETHYSMOGRAPHY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
TIME;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIUM;
ACETYLCYSTEINE;
ADULT;
ANEMIA, IRON-DEFICIENCY;
ANTIOXIDANTS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
ENDOTHELIUM, VASCULAR;
FEMALE;
FERRIC COMPOUNDS;
HEMATINICS;
HUMANS;
INDIA;
INFUSIONS, INTRAVENOUS;
LIPID PEROXIDATION;
MALE;
MALONDIALDEHYDE;
MIDDLE AGED;
OXIDATIVE STRESS;
PLACEBO EFFECT;
PLETHYSMOGRAPHY;
PROSPECTIVE STUDIES;
RENAL DIALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 79952062302
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (24)
|
References (0)
|